Tidal Investments’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Tidal Investments's NVS Position: Q1 2026 in Review
Tidal Investments reduced its Novartis (NVS) stake by 15% in Q1 2026, selling an estimated $5.07M and leaving 193,177 shares worth $29.4M. The position accounts for 0.06% of the portfolio, ranked #272.
Tidal Investments first reported a position in NVS in Q1 2024 and has held it in 9 quarters since. The position peaked at $38.7M in Q3 2025. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Tidal Investments held 193,177 shares of Novartis worth $29.4M as of Q1 2026.
- Tidal Investments sold 33,079 Novartis shares in Q1 2026, an estimated $5.07M.
- Novartis made up 0.06% of Tidal Investments's portfolio in Q1 2026, its #272 holding.
- Tidal Investments first reported a position in Novartis in Q1 2024 and has held it in 9 quarters since.
- Tidal Investments's Novartis position peaked at $38.7M in Q3 2025.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.